Science Explorer Back to mapMap
Discussion
Company · Rockville · United States

CASI Pharmaceuticals (United States)

casipharmaceuticals.comROR OpenAlex
Research works
117
▲ 3% vs 2018-21
Citations
6.5k
55.1 per fractional work
Top-10% rate
9.7%
all institutions 10.0%
Open access
30%
world 40%
International
20%
world 18%
CASI Pharmaceuticals (United States)

Not ranked overall: CASI Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does CASI Pharmaceuticals (United States) work in?

In all years, 46% of research at CASI Pharmaceuticals (United States) is in Life Sciences, 38% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (36%), Medicine (35%), Immunology and Microbiology (7%). It does 2.8× the world's share of Life Sciences.

Life Sciences: 54 fractional works · 46.2% of its workBiochemistry, Genetics and Molecular Biology: 42 fractional works · 35.6% of its workMolecular Biology: 24 fractional works · 20.5% of its workCancer Research: 6 fractional works · 5.3% of its workGenetics: 5 fractional works · 4.6% of its workCell Biology: 4 fractional works · 3.4% of its workBiotechnology: 2 fractional works · 1.3% of its workBiochemistry: 0 fractional works · 0.4% of its workImmunology and Microbiology: 8 fractional works · 7.2% of its workImmunology: 7 fractional works · 5.7% of its workVirology: 1 fractional works · 0.7% of its workMicrobiology: 0 fractional works · 0.4% of its workParasitology: 0 fractional works · 0.4% of its workNeuroscience: 2 fractional works · 1.3% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.6% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.2% of its workToxicology: 1 fractional works · 1.0% of its workPharmacology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.9% of its workPlant Science: 1 fractional works · 0.5% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Sciences: 45 fractional works · 38.2% of its workMedicine: 41 fractional works · 35.2% of its workOncology: 8 fractional works · 7.1% of its workPublic Health, Environmental and Occupational Health: 5 fractional works · 4.2% of its workSurgery: 3 fractional works · 2.9% of its workPulmonary and Respiratory Medicine: 3 fractional works · 2.7% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 2.5% of its workEndocrinology, Diabetes and Metabolism: 3 fractional works · 2.1% of its workImmunology and Allergy: 2 fractional works · 1.7% of its workHematology: 2 fractional works · 1.6% of its workPhysiology: 2 fractional works · 1.3% of its workRheumatology: 2 fractional works · 1.3% of its workGenetics: 1 fractional works · 1.2% of its workPathology and Forensic Medicine: 1 fractional works · 1.2% of its workEpidemiology: 1 fractional works · 1.1% of its workPharmacology: 1 fractional works · 0.9% of its workHepatology: 1 fractional works · 0.6% of its workInfectious Diseases: 1 fractional works · 0.6% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workInternal Medicine: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 1.3% of its workHealth Professions: 3 fractional works · 2.6% of its workGeneral Health Professions: 2 fractional works · 1.4% of its workHealth Information Management: 1 fractional works · 0.7% of its workOccupational Therapy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.4% of its workIssues, ethics and legal aspects: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 10 fractional works · 8.5% of its workEngineering: 4 fractional works · 3.6% of its workBiomedical Engineering: 1 fractional works · 1.2% of its workOcean Engineering: 1 fractional works · 0.9% of its workAerospace Engineering: 1 fractional works · 0.5% of its workMechanics of Materials: 0 fractional works · 0.4% of its workBuilding and Construction: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workChemistry: 2 fractional works · 2.0% of its workOrganic Chemistry: 2 fractional works · 1.7% of its workSpectroscopy: 0 fractional works · 0.3% of its workComputer Science: 2 fractional works · 1.3% of its workComputational Theory and Mathematics: 1 fractional works · 0.6% of its workHuman-Computer Interaction: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.5% of its workEnvironmental Science: 1 fractional works · 0.5% of its workWater Science and Technology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMaterials Science: 1 fractional works · 0.5% of its workBiomaterials: 1 fractional works · 0.5% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workRadiation: 0 fractional works · 0.4% of its workEnergy: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 8 fractional works · 7.1% of its workSocial Sciences: 4 fractional works · 3.7% of its workEducation: 2 fractional works · 1.6% of its workSociology and Political Science: 1 fractional works · 0.5% of its workDemography: 0 fractional works · 0.3% of its workLinguistics and Language: 0 fractional works · 0.3% of its workGeography, Planning and Development: 0 fractional works · 0.2% of its workUrban Studies: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.6% of its workBusiness, Management and Accounting: 1 fractional works · 1.0% of its workAccounting: 1 fractional works · 0.5% of its workManagement of Technology and Innovation: 0 fractional works · 0.3% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.3% of its workPsychology: 1 fractional works · 1.0% of its workApplied Psychology: 0 fractional works · 0.3% of its workClinical Psychology: 0 fractional works · 0.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 1 fractional works · 0.8% of its workLanguage and Linguistics: 0 fractional works · 0.3% of its workPhilosophy: 0 fractional works · 0.3% of its workLiterature and Literary Theory: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKCASIPharmaceuticals…117fractional works, all years
Life Sciences46%Physical Sciences8%Health Sciences38%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology4235.6%
    2. Immunology and Microbiology87.2%
    3. Neuroscience21.3%
    4. Pharmacology, Toxicology and Pharmaceutics11.2%
    5. Agricultural and Biological Sciences10.9%
    1. Medicine4135.2%
    2. Health Professions32.6%
    3. Nursing00.4%
    1. Engineering43.6%
    2. Chemistry22.0%
    3. Computer Science21.3%
    4. Environmental Science10.5%
    5. Materials Science10.5%
    6. Physics and Astronomy00.4%
    7. Energy00.1%
    8. Earth and Planetary Sciences00.1%
    1. Social Sciences43.7%
    2. Business, Management and Accounting11.0%
    3. Psychology11.0%
    4. Arts and Humanities10.8%
    5. Economics, Econometrics and Finance00.4%
    6. Decision Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.54× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.07× its world share, 0 worksImmunology and Micro…Neuroscience: 3.08× its world share, 0 worksNeuroscienceComputer Science: 0.15× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.77× its world share, 0 worksEarth and Planetary …Engineering: 0.91× its world share, 1 worksEngineeringEnvironmental Science: 0.36× its world share, 0 worksEnvironmental ScienceHealth Professions: 2.93× its world share, 1 worksHealth ProfessionsMedicine: 1.70× its world share, 3 worksMedicineArts and Humanities: 0.31× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.56× its world share, 0 worksEconomics, Econometr…Psychology: 1.26× its world share, 0 worksPsychologySocial Sciences: 1.64× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 3.1×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Neuroscience3.08×0 works
  2. Health Professions2.93×1 works
  3. Medicine1.70×3 works
  4. Social Sciences1.64×2 works
  5. Biochemistry, Genetics and Molecular Biology1.54×1 works
  6. Psychology1.26×0 works
  7. Immunology and Microbiology1.07×0 works
  8. Engineering0.91×1 works
  9. Earth and Planetary Sciences0.77×0 works
  10. Economics, Econometrics and Finance0.56×0 works
  11. Environmental Science0.36×0 works
  12. Arts and Humanities0.31×0 works
  13. Agricultural and Biological Sciences0.15×0 works
  14. Computer Science0.15×0 works

Who are the top researchers at CASI Pharmaceuticals (United States)?

Ranked on the quality score, Shawn J. Green, Victor S. Pribluda and B. Kim Lee Sim lead among researchers whose main affiliation is CASI Pharmaceuticals (United States).

  1. 1 Shawn J. Green United States · #415,557 worldwide 5.6k citations · 69 works
  2. 2 Victor S. Pribluda United States · #586,580 worldwide 3.4k citations · 38 works
  3. 3 B. Kim Lee Sim United States · #831,675 worldwide 3.7k citations · 47 works
  4. 4 Carolyn Fowler Sidor United States · #846,953 worldwide 2.2k citations · 67 works
  5. 5 Jamie Arnott United States · #1,293,033 worldwide 529 citations · 29 works
  6. 6 Anand K. Iyer United States · #2,132,030 worldwide 309 citations · 24 works
  7. 7 Hong Liang United States · #2,887,867 worldwide 410 citations · 16 works
  8. 8 Steven R. Fuhrmann United States · #3,008,326 worldwide 928 citations · 18 works
  9. 9 Jamshed H. Shah United States · #4,504,311 worldwide 466 citations · 17 works
All ranked researchers at CASI Pharmaceuticals (United States)

What are the most cited papers from CASI Pharmaceuticals (United States)?

The most cited paper from CASI Pharmaceuticals (United States) is "Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages" (Ryutaro Kamijo, Hisashi Harada, T. Matsuyama et al., 1994), with 845 citations. Next come "2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF" (732) and "A Systematic Review of Reviews Evaluating Technology-Enabled Diabetes Self-Management Education and Support" (568).

Most cited papers
#PaperReleasedCitations
1 Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages Ryutaro Kamijo, Hisashi Harada, T. Matsuyama et al. · Science 18 Mar 1994 845
2 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF Nicola J. Mabjeesh, Daniel Escuín, Theresa M. LaVallee et al. · Cancer Cell Open access Apr 2003 732
3 A Systematic Review of Reviews Evaluating Technology-Enabled Diabetes Self-Management Education and Support Deborah A. Greenwood, Perry M. Gee, Kathy J. Fatkin et al. · Journal of Diabetes Science and Technology ReviewOpen access 31 May 2017 568
4 Withaferin A is a potent inhibitor of angiogenesis Royce Mohan, Hans J. Hammers, Paola Bargagna‐Mohan et al. · Angiogenesis 2004 383
5 2017 National Standards for Diabetes Self-Management Education and Support Joni K. Beck et al. · Diabetes Care 28 Jul 2017 367
All 60 most cited papers, with filters and sorting

Which keywords describe research at CASI Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Breast Cancer, Cancer, Cancer Therapy, Signaling, endothelial progenitor cells, VEGF and Receptor.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation10▲ 3.7×28 topics
  2. Cancer8▲ 4.9×19 topics
  3. Epidemiology8▲ 1.59×20 topics
  4. Breast Cancer7▲ 21×7 topics
  5. Cancer Therapy6▲ 8.3×10 topics
  6. Signaling6▲ 45×4 topics
  7. VEGF6▲ 146×1 topic
  8. endothelial progenitor cells6▲ 146×1 topic
  9. Receptor6▲ 66×2 topics
  10. Angiogenesis5▲ 11×8 topics
  11. Transcriptional Regulation5▲ 17×3 topics
  12. Estrogen5▲ 56×2 topics
  13. Nuclear Receptors5▲ 23×3 topics
  14. Glucocorticoids4▲ 68×1 topic
  15. Tamoxifen4▲ 68×1 topic
  16. Chemotherapy4▲ 5.2×11 topics
  17. Vaccine Development4▲ 12×4 topics
  18. Cell Signaling4▲ 10×6 topics
  19. Metabolism4▲ 5.1×10 topics
  20. Tumor Microenvironment4▲ 9.5×5 topics
  21. Glycosylation4▲ 15×3 topics
  22. Drug Discovery4▲ 8.0×5 topics
  23. Immunotherapy4▲ 4.7×9 topics
  24. Apoptosis4▲ 7.6×8 topics
  25. Immunity3▲ 8.2×7 topics
  26. Protein-Protein Interactions3▲ 25×2 topics
  27. Innate Immunity3▲ 7.4×7 topics
  28. HIF-13▲ 34×1 topic
  29. Pharmacology3▲ 7.5×6 topics
  30. Warburg Effect3▲ 34×1 topic
  31. Extracellular Matrix3▲ 9.7×3 topics
  32. Fc Receptors3▲ 22×1 topic
  33. Therapeutic Antibodies3▲ 17×1 topic
  34. Cell Division2▲ 59×1 topic
  35. Insecticide Resistance2▲ 22×2 topics
  36. Microtubules2▲ 59×1 topic
  37. Artemisinin Resistance2▲ 53×1 topic
  38. Cancer Progression2▲ 9.1×5 topics
  39. Foldamers2▲ 26×1 topic
  40. Peptide Synthesis2▲ 26×1 topic

Which research topics does CASI Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Education Pedagogy and Practices, Diabetes Management and Research, Mobile Health and mHealth Applications and Alzheimer's disease research and treatments.

Education Pedagogy and P…0Education Pedagogy and Practices: 0 fractional worksDiabetes Management and …0Diabetes Management and Research: 0 fractional worksMobile Health and mHealth Applications: 0 fractional worksAlzheimer's disease research and treatments: 0 fractional worksOil and Gas Production Techniques: 0 fractional worksMarine and Offshore Engineering Studies: 0 fractional worksDiabetes Management and Education: 0 fractional worksReservoir Engineering an…0Reservoir Engineering and Simulation Methods: 0 fractional worksCholinesterase and Neurodegenerative Diseases: 0 fractional worksBiochemical and Structural Characterization: 0 fractional works
EducationEndocrinology, Diabetes and MetabolismGeneral Health ProfessionsPhysiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Education Pedagogy and Practices Education 0 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Mobile Health and mHealth Applications General Health Professions 0 works
  4. 4 Alzheimer's disease research and treatments Physiology 0 works
  5. 5 Oil and Gas Production Techniques Ocean Engineering 0 works
  6. 6 Marine and Offshore Engineering Studies Ocean Engineering 0 works
  7. 7 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Reservoir Engineering and Simulation Methods Ocean Engineering 0 works
  9. 9 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
  10. 10 Biochemical and Structural Characterization Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.5%not open69.5%

World: 40% of research is openly available.

with international co-authors19.7%domestic only80.3%

World: 18% is written across borders.

How has CASI Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 3% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is CASI Pharmaceuticals (United States) as a percentage of every work published that year, 0.000023% in 2024.

still counting0.00025%0.00050%0.00075%CASI Pharmaceuticals (United States)0.000047% in 20251990200020102020

Fractional works of CASI Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rockville

All research institutions in Rockville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about CASI Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.